Pfizer Turns To Insider Ian Read To Lead Into Post-Lipitor Era
This article was originally published in The Tan Sheet
Executive Summary
Pfizer's election of Ian Read as president, CEO and director of the company sets the stage for a management transition at the firm, which has underperformed its peers on several measures in recent years.
You may also be interested in...
Pfizer CEO Read Expects Gradual Plans For Change In Second Half 2011
Pfizer expects to unveil restructuring plans, including the potential divestiture of its Consumer Healthcare and Nutrition units, in the second half of 2011.
Capsugel Could Land In Private Equity Crosshairs If Pfizer Divests
Capsugel likely will be the first divestiture from Pfizer's Diversified Businesses following the 2009 Wyeth merger and reorganization, and could be a prime target for a private equity acquisition
Pfizer Exits Eight Manufacturing Sites And Slices Jobs In Six More
Pfizer will stop production of consumer health care products in Virginia and New York while expanding its consumer product operations in Puerto Rico in a realignment of its manufacturing network